Journal article · 2022 · Open access

Biocompatibility Testing Standards for Implantable Devices

Léa Da Costa, Amelia Petrov, Pierre Horvath

International Journal of Drug and Medical Device Research · Published 20 March 2022 · DOI 10.5281/zenodo.19550253

Free PDFView at the publisherCite this paper

In brief

“Biocompatibility Testing Standards for Implantable Devices” is a 2022 journal article by Léa Da Costa and 2 co-authors, published in International Journal of Drug and Medical Device Research. OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at International Journal of Drug and Medical Device Research.

Citations
0
Authors
3

Abstract

Biocompatibility -- the ability of a material to perform its intended function without eliciting an unacceptable biologicalresponse -- is the foundational safety requirement for implantable medical devices. ISO 10993 (Biological evaluation ofmedical devices) defines a comprehensive testing framework spanning cytotoxicity, sensitisation, irritation, systemictoxicity, genotoxicity, haemocompatibility, implantation effects, and chronic toxicity. However, ISO 10993 testing isexpensive (USD 200,000-500,000 per device), time-consuming (12-18 months), requires extensive animal testing(2,000-5,000 animals per full battery), and provides limited predictive validity for human clinical outcomes due to speciesdifferences in immune response and tissue healing. Computational and in vitro alternative approaches -- moleculardynamics simulation of protein-surface interactions, organ-on-chip tissue models, AI-based toxicity prediction,high-throughput cell-based screening, and integrated testing strategies -- promise to improve biocompatibilityassessment accuracy while reducing cost, time, and animal use. We present the Biocompatibility Assessment InnovationFramework (BAIF), evaluating five alternative approaches across four implant material categories (metallic alloys,polymers, ceramics, and composite biomaterials). Our Biocompatibility Assessment Score (BAS) measures predictiveaccuracy, biological relevance, regulatory acceptance, animal reduction potential, and throughput. Organ-on-chip tissuemodels achieve the highest BAS (0.924) through human-cell-based systems that recapitulate the tissuemicroenvironment with higher species relevance than animal testing, while AI toxicity prediction achieves the highestthroughput (0.960) through in silico screening of thousands of material compositions before any physical testing

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Da Costa, L., Petrov, A., & Horvath, P. (2022). Biocompatibility Testing Standards for Implantable Devices. International Journal of Drug and Medical Device Research. https://doi.org/10.5281/zenodo.19550253

MLA 9

Da Costa, Léa, et al. “Biocompatibility Testing Standards for Implantable Devices.” International Journal of Drug and Medical Device Research, 2022. https://doi.org/10.5281/zenodo.19550253.

Chicago

Da Costa, Léa, Amelia Petrov, and Pierre Horvath. 2022. “Biocompatibility Testing Standards for Implantable Devices.” International Journal of Drug and Medical Device Research. https://doi.org/10.5281/zenodo.19550253.

Harvard

Da Costa, L., Petrov, A. and Horvath, P. (2022) ‘Biocompatibility Testing Standards for Implantable Devices’, International Journal of Drug and Medical Device Research. doi:10.5281/zenodo.19550253.

IEEE

L. Da Costa, A. Petrov, and P. Horvath, “Biocompatibility Testing Standards for Implantable Devices,” International Journal of Drug and Medical Device Research, 2022, doi: 10.5281/zenodo.19550253.

BibTeX

@article{dacosta2022biocompatibility,
  title     = {{Biocompatibility Testing Standards for Implantable Devices}},
  author    = {Da Costa, Léa and Petrov, Amelia and Horvath, Pierre},
  journal   = {International Journal of Drug and Medical Device Research},
  year      = {2022},
  doi       = {10.5281/zenodo.19550253},
  url       = {https://doi.org/10.5281/zenodo.19550253}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Veterinary › Small Animals › Animal testing and alternatives

  • biocompatibility testing
  • biomedical implants
  • ISO 10993
  • alternative test methods
  • organ-on-a-chip
  • molecular dynamics simulation
  • animal testing reduction
  • alloys

Work with this paper

Most-cited papers in Veterinary

All highly cited Veterinary papers

Questions about this paper

How do I cite this paper in APA style?

Da Costa, L., Petrov, A., & Horvath, P. (2022). Biocompatibility Testing Standards for Implantable Devices. International Journal of Drug and Medical Device Research. https://doi.org/10.5281/zenodo.19550253

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at International Journal of Drug and Medical Device Research.

Who wrote this paper?

Léa Da Costa, Amelia Petrov, Pierre Horvath.

What is the DOI of this paper?

10.5281/zenodo.19550253. The permanent link is https://doi.org/10.5281/zenodo.19550253.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.